Karmanos Cancer Institute Karmonos Cancer Instit. (40) — Detroit, Michigan

Karmanos Cancer Institute Karmonos Cancer Instit. (40) is a clinical research site located in Detroit, Michigan, United States 48201.

Crixeo Health Trust Score: 51/100 (POOR). This profile has not yet been claimed by the site owner.

Karmanos Cancer Institute Karmonos Cancer Instit. (40) has participated in 1 clinical trials.

Therapeutic areas: Gastrointestinal Stromal Tumor (GIST).

Sponsors: Novartis Pharmaceuticals.

Sponsor Feasibility Report

Trust Score: 51/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Karmanos Cancer Institute Karmonos Cancer Instit. (40)?

Karmanos Cancer Institute Karmonos Cancer Instit. (40) has a Crixeo Trust Score of 51/100 (POOR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Karmanos Cancer Institute Karmonos Cancer Instit. (40) conducted?

Karmanos Cancer Institute Karmonos Cancer Instit. (40) has 1 clinical trials on record. Their work covers Gastrointestinal Stromal Tumor (GIST).

Is Karmanos Cancer Institute Karmonos Cancer Instit. (40) accredited by Crixeo Health?

Karmanos Cancer Institute Karmonos Cancer Instit. (40) has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Karmanos Cancer Institute Karmonos Cancer Instit. (40)?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.